SNGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Soligenix Inc (SNGX) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock shows bearish technical indicators, lacks significant positive trading trends, and has no recent AI or SwingMax trading signals. While the company has some positive news regarding its clinical trials and cash balance, its financial performance remains weak, with negative EPS and no revenue growth. Given the investor's profile and the lack of immediate catalysts, holding off on buying this stock is recommended.
The technical indicators for SNGX are bearish. The MACD is below zero and negatively expanding, the RSI is neutral at 40.647, and the moving averages show a bearish pattern (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 1.133, with resistance levels at 1.221 and 1.275 and support levels at 1.045 and 0.991.
Additionally, the company reported a cash balance of $7.9 million, sufficient to support operations into Q4 2026.
The company reported a FY GAAP EPS of -$2.14, and its financials show no revenue growth, negative net income, and a declining EPS. Technical indicators are bearish, and there is no significant trading activity from hedge funds, insiders, or Congress.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$2.53 million (improved by 47.20% YoY), and a declining EPS of -0.58 (down 25.64% YoY). The gross margin remains at 0%.
No recent analyst rating or price target data is available for SNGX.
